ALKS - Alkermes Q4 2023 Earnings Preview
2024-02-14 11:25:34 ET
More on Alkermes
- Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage
- Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet
- Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M
- Seeking Alpha’s Quant Rating on Alkermes
- Historical earnings data for Alkermes